Genhouse Bio Appointed Dr. Jie Jack Li as Chief Scientific Officer


On January 4th 2022, Genhouse Bio, a biotech company focusing on development of next-generation small molecule anti-cancer therapeutics, announced today that Genhouse Bio has appointed Dr. Jie Jack Li as Chief Scientific Officer (CSO). Dr. Li will drive Global Drug Discovery in Genhouse, strengthen its original innovation capability and accelerate the translation from drug discovery to clinical.




Dr. Jie Jack Li has had over 25 years of experience in medicinal chemistry and drug discovery in both big pharma and biotechnology companies in the US including Pfizer, BMS, and Revolution Medicines. He has made important contributions in projects encompassing several therapeutic areas including virology and oncology. In addition, Dr. Li took a four-year sojourn as an associate professor at the University of San Francisco, teaching medicinal chemistry and organic chemistry. Before joining GenHouse, Dr. was a vice president of Discovery Chemistry at ChemPartner.


Dr. Li has written extensively in the fields of organic chemistry, medicinal chemistry, and history of drug discovery. In addition to 34 research articles and 12 patents, he has published over 30 books on organic chemistry, medicinal chemistry, and history of drug discovery. He published 10 books with Nobel Laureate E. J. Corey. His book “Name Reactions: A Collection of Detailed Mechanisms and Synthetic Applications”, now in its 6th edition, is popular worldwide, having educated a generation of organic chemists.


In terms of education, Dr. Li earned his B.S. and M.S. degrees in polymer chemistry at Nanjing University in 1983 and 1987, respectively. After having earned his Ph.D. in Organic Chemistry from Indiana University in 1995, he carried out his postdoctoral research at Massachusetts Institute of Technology.


“We are honored to have Dr. Jie Jack Li as CSO,” said Dr. Kuifeng Wang, founder and CEO of Genhouse, “Dr. Li brings his profound knowledge about Medicinal Chemistry and multi-year experience of new drug development in MNC. We believe Dr. Li will strengthen the drug discovery capability of Genhouse and bring more and better therapeutic choices to global patients.”


“Genhouse has a highly innovative pipeline that aims to solve global unmet medical need,” said Dr. Jie Jack Li, “I am honored to join this company with high potential and am looking forward to overcoming “undruggable” targets with Genhouse and bringing more products with global value to the market to benefit global cancer patients.”

Privacy Statement

Genhouse Bio (Suzhou) Ltd. (“Genhouse” or “We”) respects the privacy of visitors (“Users”) to our website (“Site”), so we have developed this website privacy statement (“Privacy Statement”). This Privacy Statement indicates what information we collect about you and how that information is used. We may update the content of the Privacy Statement and suggest reading it regularly when you visit our Site.

Personal Information Collected by Genhouse

When you visit the Site, usually we will not collect any personal information from you. We might track your DNS and analyze the data to obtain understanding on visit trends. However, your identity will always remain anonymous, unless you specifically and knowingly provide it to us. When you provide such information, we will collect your personal information, such as when you contact us through the phone number or email address posted on the Site. But no matter when and how we collect your personal information, we will always provide link to this Privacy Statement. By willingly providing your personal information to us, you make the consent that we could use the information collected according to this Privacy Statement and admit that the information will be transferred from your locale to our office or server.

Information Disclosures and Sharing

Except as provided below, we will not share or sell your Personal Information with third parties unless otherwise stated by this Privacy Statement.

We might share your information according to this Privacy Statement, with Related Party who have consented to follow this Privacy Statement. Your personal information might also be transferred to other Related Party who represents us for purpose stated when we collect those information or other purposes permitted by law, such as Site evaluation, data management or technical support.

We might sell or buy business or assets during our operation. If Genhouse is acquired, merged, reorganized or dissolved or other alike situations happened, personal information might be part of the assets transferred. We may share personal information to respond to duly authorized subpoenas or other lawful information requests of governmental authorities, including to meet national security or law enforcement requirements, to provide Internet security, or where required by law.


We might put a digital tag (more precisely “cookies”) on your hard disk driver for the server to recognize your computer and track usage information. Cookies will not reveal your personal information and you could always stay anonymous to us. The information we collected from Cookies will only be used for internal purpose and improve the service we provided to you through the Site. Users of our Site always have the option of disabling cookies via their browser preferences. If under any circumstances we collected your personal information, we will always inform you with your planned usage, contact and any Third Party that might get this information. All your personal information will maintain secrecy.

Links to Other Websites

If you apply to a job through our Site, you might be directed to other websites operated by Third Party. This Privacy Statement does not extend to any of these websites. Genhouse will not be responsible for any personal information collected by these websites operated by Third Party. Therefore, for any cases that a Third Party collect or use your personal information, Genhouse will not be legally responsible. We advise you to contact those websites directly and get their policies on personal information collection, safety, sharing and disclosure.

Contact Information

If you have any questions about our Privacy Statement, please do not hesitate to contact us at [].

Effective and Last Updated: April 15th 2021